Columbus Circle Investors’s TherapeuticsMD TXMD Stock Holding History

Columbus Circle Investors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-40,356	Closed	-$10.7M	–	270
2017 Q3	$10.7M	Sell	40,356 -2,328	-5%	-$673K	0.18%	133
2017 Q2	$11.2M	Buy	42,684 +6,025	+16%	+$1.51M	0.19%	121
2017 Q1	$13.2M	Buy	36,659 +26,092	+247%	+$8.07M	0.19%	131
2016 Q4	$3.05M	Buy	10,567 +7,935	+301%	+$2.46M	0.04%	206
2016 Q3	$896K	Buy	2,632 +1,472	+127%	+$538K	0.01%	257
2016 Q2	$493K	Buy	+1,160	New	+$478K	﹤0.01%	244
2015 Q4	–	Sell	-2,279	Closed	-$668K	–	310
2015 Q3	$668K	Sell	2,279 -973	-30%	-$346K	0.01%	260
2015 Q2	$1.28M	Buy	3,252 +1,499	+86%	+$529K	0.01%	249
2015 Q1	$530K	Buy	+1,753	New	+$428K	﹤0.01%	275

Other funds holding TXMD

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Columbus Circle Investors's TXMD Position: Q4 2017 in Review

Columbus Circle Investors sold out of TherapeuticsMD (TXMD) in Q4 2017, closing a stake of 40,356 shares — an estimated $10.7M sold.

Columbus Circle Investors first reported a position in TXMD in Q1 2015 and held it in 9 quarters. The position peaked at $13.2M in Q1 2017. 144 funds tracked by Wall St. Rank hold TXMD as of Q4 2017.

Columbus Circle Investors reported no remaining TherapeuticsMD position as of Q4 2017 after selling out during the quarter.
Columbus Circle Investors sold 40,356 TherapeuticsMD shares in Q4 2017, an estimated $10.7M.
Columbus Circle Investors first reported a position in TherapeuticsMD in Q1 2015 and held it in 9 quarters.
Columbus Circle Investors's TherapeuticsMD position peaked at $13.2M in Q1 2017.
144 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.